FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

NeuBase Therapeutics, Inc.: capex

One fact, its scope and the complete path back to the official record.

Period: 2021-10-01 – 2022-06-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/19fd6428-5e49-4107-a809-8bfb1fd041f6

Reported value

$442.905k{"amount": 442905, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Entity
NeuBase Therapeutics, Inc.
Metric
capex
Period
2021-10-01 – 2022-06-30
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001410578-22-002236 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T11:48:38.819311+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001173281/capex/2022-06-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.